Patterson Companies Completes Transition to Private Ownership
04.02.2026 - 21:54:04
The distributor of dental and animal health products, Patterson Companies, has finalized its departure from public markets. The move concludes a strategic review and a definitive acquisition agreement reached in December 2024. The company's shares are no longer listed on the NASDAQ Global Select Market as of the transaction's closing last April.
The transition to private ownership was executed through an acquisition by Patient Square Capital, an investment firm with a dedicated focus on the healthcare sector. The firm reported approximately $12 billion in assets under management as of the end of 2024. The all-cash transaction valued Patterson at roughly $4.1 billion, which includes the refinancing of certain existing debts.
Under the terms of the deal, public shareholders received a cash payment of $31.35 for each share they held. This outcome followed a comprehensive evaluation of strategic alternatives by Patterson's Board of Directors, which aimed to maximize value for its shareholders.
Should investors sell immediately? Or is it worth buying Patterson?
Leadership and Operational Shifts Post-Transaction
Concurrent with the privatization, Patterson Companies instituted a change in its executive leadership. Robert Rajalingam has been appointed as the new Chief Executive Officer, succeeding Don Zurbay. The company will now operate under the guidance of its new private equity owner.
This shift in corporate structure brings significant operational changes. Liberated from the demands of public markets, Patterson is no longer required to issue quarterly reports or manage its strategy in response to short-term stock price fluctuations. Management can now direct its full attention toward long-term business objectives in its core dental and animal health segments across North America and the United Kingdom.
The financial backing and industry expertise of Patient Square Capital are expected to support Patterson's strategic repositioning and efforts to strengthen its market position. The company aims to pursue its growth plans away from the scrutiny and expectations inherent to publicly traded equity markets.
Ad
Patterson Stock: Buy or Sell?! New Patterson Analysis from February 4 delivers the answer:
The latest Patterson figures speak for themselves: Urgent action needed for Patterson investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 4.
Patterson: Buy or sell? Read more here...
